Clinical

Dataset Information

0

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer


ABSTRACT: The purpose of this study is to test the safety and efficacy of an experimental drug, OMP-305B83, when given in combination with FOLFIRI or FOLFOX. OMP-305B83 is a humanized bispecific monoclonal antibody and was developed to target cancer stem cells. Based on preclinical studies, it is believed that OMP-305B83 may block the growth of cancer stem cells and may also impair the productive growth of new blood vessels, which tumors need to grow and spread. The study is sponsored by OncoMed Pharmaceuticals, which is referred to as OncoMed or the Sponsor.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2235323 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-09-02 | BIOMD0000000819 | BioModels
2024-03-03 | GSE260674 | GEO
2021-05-25 | GSE151867 | GEO
2021-12-20 | GSE189359 | GEO
2020-01-20 | MODEL2001200002 | BioModels
| 2106666 | ecrin-mdr-crc
2023-08-15 | GSE240489 | GEO
2023-01-27 | PXD023034 | Pride
2015-03-04 | E-GEOD-62933 | biostudies-arrayexpress
| PRJNA147551 | ENA